SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056509
Filing Date
2021-11-12
Accepted
2021-11-12 08:28:35
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prld-10q_20210930.htm   iXBRL 10-Q 3831504
2 EX-31.1 prld-ex311_9.htm EX-31.1 20895
3 EX-31.2 prld-ex312_7.htm EX-31.2 20907
4 EX-32.1 prld-ex321_8.htm EX-32.1 10247
5 EX-32.2 prld-ex322_6.htm EX-32.2 10322
  Complete submission text file 0001564590-21-056509.txt   8205392

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA prld-20210930.xsd EX-101.SCH 38015
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prld-20210930_cal.xml EX-101.CAL 33337
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prld-20210930_def.xml EX-101.DEF 160193
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20210930_lab.xml EX-101.LAB 320177
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20210930_pre.xml EX-101.PRE 245647
11 EXTRACTED XBRL INSTANCE DOCUMENT prld-10q_20210930_htm.xml XML 969969
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 211399908
SIC: 2834 Pharmaceutical Preparations